Glio- and neurotransmitters: significance in brain disease
This symposium will highlight the emerging importance of the roles of glia-neuronal interactions in brain function and disease processes.
Program
11:45 Arrive – Refreshments, Coffee, Tea
- 12:00 Welcome by Linda H Bergersen / Jon Storm-Mathisen
- 12:10 J Victor Nadler: Aspartate release and signaling in the brain
- 12:35 Albert Gjedde: DOPA transmission – a novel monoaminergic mechanism of depression and dyskinesia in Parkinson’s disease
- 13:00 Anders Björklund: Use of stem cells for dopamine cell replacement i Parkinson’s disease
- 13:25 Espen Dietrichs: How does deep brain stimulation work in movement disorders?
13:50 Refreshments, Coffee, Tea
- 14:10 David Attwell: The energetics of CNS white matter
- 14:35 Erlingur Johannsson: Effects of a 6-month multimodal training intervention on retention of functional performance, body composition and metabolic syndrome factors in older adults
- 15:00 Vidar Steen: Lipogenic effects of antipsychotic drugs in glial cells: relevance for therapeutic efficacy?
- 15:25 Ursula Sonnewald: Glia-neuronal interplay of transmitters and metabolic intermediates – relevance for brain diseases
- 15:50 Farrukh A Chaudhry: Glutamate and GABA recycling through glutamine – what is the significance?
16:15 Refreshments, Coffee, Tea
- 16:35 Magnar Bjørås: DNA repair deficiency in neurodegeneration
- 17:00 Robert H Edwards: The membrane interactions of alpha-synuclein
- 17:25 Reidun Torp: Understanding plaque formation in models of Alzheimer’s disease by use of microscopic techniques
- 17:50 Tone Tønjum: Glial responses to bacterial meningitis
- 18:15 Ole Petter Ottersen: New insight in the homeostatic roles of astrocytes
18:40 End of Symposium
19:00 Dinner (by special invitation)
Published Feb 2, 2012 02:13 PM